CHELSEA BAUMGARDNER: Open Payments
NPI 1063011468 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,165 in 67 payments from 15 companies in 2025. Trend: 2023 $156 · 2024 $317 · 2025 $1,165
Food & beverage: $1,165
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $328 |
| ABBVIE INC. | 14 | $248 |
| AstraZeneca Pharmaceuticals LP | 7 | $141 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $93 |
| Lilly USA, LLC | 3 | $55 |
| PFIZER INC. | 3 | $48 |
| Amgen Inc. | 3 | $47 |
| Exact Sciences Corporation | 3 | $44 |
| Kowa Pharmaceuticals America, Inc. | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
Products named: Wegovy, VRAYLAR, AIRSUPRA, QULIPTA, CAPLYTA, Rybelsus, Ozempic, MOUNJARO.
Industry payments across KY — which companies pay providers there.
